YaSheng Group
HERB · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $12,730 | $24,361 | $16,220 | $20,432 |
| - Cash | $4,993 | $4,711 | $4,176 | $6,556 |
| + Debt | $2,304 | $2,257 | $1,686 | $2,269 |
| Enterprise Value | $10,042 | $21,907 | $13,730 | $16,145 |
| Revenue | $5,900 | $4,086 | $4,564 | $5,765 |
| % Growth | 44.4% | -10.5% | -20.8% | – |
| Gross Profit | $1,991 | $1,385 | $1,036 | $1,923 |
| % Margin | 33.7% | 33.9% | 22.7% | 33.4% |
| EBITDA | $2,058 | $1,439 | $1,107 | $1,899 |
| % Margin | 34.9% | 35.2% | 24.2% | 32.9% |
| Net Income | $1,935 | $1,364 | $848 | $1,891 |
| % Margin | 32.8% | 33.4% | 18.6% | 32.8% |
| EPS Diluted | 0.012 | 0.009 | 0.005 | 0.012 |
| % Growth | 41.4% | 61.1% | -55% | – |
| Operating Cash Flow | $392 | $1,598 | -$240 | $615 |
| Capital Expenditures | -$865 | -$636 | -$1,719 | $34 |
| Free Cash Flow | -$473 | $962 | -$1,959 | $650 |